Provectus Biopharmaceuticals (PVCT) Short Interest Ratio & Short Volume $0.08 +0.00 (+6.11%) As of 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Provectus Biopharmaceuticals Short Interest DataProvectus Biopharmaceuticals (PVCT) has a short interest of 485,500 shares. This marks a 8.42% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 228,331 shares to cover all short positions.Current Short Interest485,500 sharesPrevious Short Interest447,800 sharesChange Vs. Previous Month+8.42%Dollar Volume Sold Short$35.78 thousandShort Interest Ratio0.9 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares420,280,000 sharesPercentage of Shares Shorted0.12%Today's Trading Volume167,415 sharesAverage Trading Volume228,331 sharesToday's Volume Vs. Average73% Short Selling Provectus Biopharmaceuticals? Sign up to receive the latest short interest report for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPVCT Short Interest Over TimePVCT Days to Cover Over TimePVCT Percentage of Float Shorted Over Time Provectus Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/2025485,500 shares $35.78 thousand +8.4%N/A0.9 $0.07 8/31/2025447,800 shares $36.00 thousand +1,781.5%0.1%1.8 $0.08 8/15/202523,800 shares $2.06 thousand -47.4%N/A0.1 $0.09 7/31/202545,200 shares $3.96 thousand +2,558.8%0.0%0.1 $0.09 7/15/20251,700 shares $123.93 +240.0%N/A0 $0.07 6/30/2025500 shares $37.45 -97.1%0.0%0 $0.07 6/15/202517,100 shares $1.26 thousand +3,320.0%0.0%0 $0.07 5/31/2025500 shares $42.55 -94.4%0.0%0 $0.09 5/15/20259,000 shares $747.00 +1,700.0%0.0%0.1 $0.08 4/30/2025500 shares $46.45 No ChangeN/A0 $0.09 Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 4/15/2025500 shares $49.25 -92.2%0.0%0 $0.10 3/31/20256,400 shares $640.00 +1,180.0%0.0%0 $0.10 3/15/2025500 shares $50.65 -97.1%0.0%0 $0.10 2/28/202517,500 shares $1.86 thousand +3,400.0%0.0%0.1 $0.11 2/15/2025500 shares $52.20 No Change0.0%0 $0.10 1/31/2025500 shares $52.80 -97.2%N/A0 $0.11 1/15/202518,000 shares $2.09 thousand +520.7%N/A0 $0.12 12/31/20242,900 shares $348.29 -65.9%N/A0 $0.12 12/15/20248,500 shares $1.09 thousand +214.8%N/A0 $0.13 11/30/20242,700 shares $318.60 +440.0%N/A0 $0.12 11/15/2024500 shares $55.05 -99.2%N/A0 $0.11 10/31/202465,600 shares $7.05 thousand +1,626.3%N/A0.2 $0.11 10/15/20243,800 shares $410.02 -93.5%N/A0 $0.11 9/30/202458,700 shares $5.75 thousand +3,568.8%N/A0.1 $0.10 9/15/20241,600 shares $159.76 -48.4%N/A0 $0.10 8/31/20243,100 shares $279.00 -91.8%N/A0 $0.09 8/15/202437,800 shares $3.28 thousand +404.0%N/A0.1 $0.09 7/31/20247,500 shares $768.75 +87.5%N/A0 $0.10 7/15/20244,000 shares $458.80 +700.0%N/A0 $0.11 6/30/2024500 shares $63.05 No ChangeN/A0 $0.13 6/15/2024500 shares $79.50 -87.8%N/A0 $0.16 5/31/20244,100 shares $690.03 +720.0%N/A0 $0.17 5/15/2024500 shares $97.15 -99.7%N/A0 $0.19 4/30/2024142,600 shares $28.38 thousand +127.8%N/A0.4 $0.20 4/15/202462,600 shares $10.49 thousand -67.2%N/A0.1 $0.17 3/31/2024190,800 shares $34.89 thousand +1,700.0%N/A0.3 $0.18 3/15/202410,600 shares $2.30 thousand -85.7%N/A0 $0.22 2/29/202474,000 shares $11.00 thousand -4.0%N/A0.2 $0.15 2/15/202477,100 shares $10.47 thousand +1,780.5%N/A0.2 $0.14 1/15/202416,300 shares $1.68 thousand -50.6%N/A0.1 $0.10 12/31/202333,000 shares $3.17 thousand +89.7%N/A0.1 $0.10 12/15/202317,400 shares $1.90 thousand +3.0%N/A0 $0.11 11/30/202316,900 shares $2.54 thousand -46.5%N/A0 $0.15 11/15/202331,600 shares $4.74 thousand +179.7%N/A0 $0.15 10/31/202311,300 shares $904.00 +2,160.0%N/A0 $0.08 10/15/2023500 shares $35.00 No ChangeN/A0 $0.07 9/30/2023500 shares $42.25 -94.8%N/A0 $0.08 9/15/20239,600 shares $943.68 +100.0%N/A0.1 $0.10 8/31/20234,800 shares $489.60 -46.1%N/A0 $0.10 8/15/20238,900 shares $845.50 +1,680.0%N/A0 $0.10 7/31/2023500 shares $54.45 -97.8%N/A0 $0.11 7/15/202322,300 shares $2.80 thousand -64.6%N/A0.1 $0.13 6/30/202363,000 shares $7.13 thousand +63.6%N/A0.1 $0.11 6/15/202338,500 shares $4.58 thousand +7,600.0%N/A0.1 $0.12 5/31/2023500 shares $67.95 -99.4%N/A0 $0.14 5/15/202381,400 shares $11.39 thousand +13,466.7%N/A0.4 $0.14 4/30/2023600 shares $80.22 -81.3%N/A0 $0.13 4/15/20233,200 shares $489.60 -96.4%N/A0 $0.15 3/31/202389,000 shares $14.69 thousand +88,900.0%N/A0.3 $0.17 3/15/2023100 shares $15.40 -99.9%N/A0 $0.15 2/28/2023116,600 shares $18.77 thousand +3,051.4%N/A0.3 $0.16 2/15/20233,700 shares $395.53 -89.5%N/A0 $0.11 1/31/202335,200 shares $4.51 thousand +262.9%N/A0.1 $0.13 1/15/20239,700 shares $1.29 thousand +9,600.0%N/A0 $0.13 12/30/2022100 shares $10.83 -99.0%N/A0 $0.11 12/15/202210,000 shares $1.10 thousand -66.6%N/A0 $0.11 11/30/202229,900 shares $2.78 thousand -45.5%N/A0 $0.09 11/15/202254,900 shares $2.84 thousand +54,800.0%N/A0.1 $0.05 10/31/2022100 shares $5.00 No ChangeN/A0 $0.05 10/15/2022100 shares $4.85 No ChangeN/A0 $0.05 9/30/2022100 shares $4.90 -99.6%N/A0 $0.05 9/15/202225,500 shares $1.35 thousand +8.5%N/A0.1 $0.05 8/31/202223,500 shares $1.28 thousand +2,511.1%N/A0.1 $0.05 8/15/2022900 shares $49.50 +80.0%N/A0 $0.06 7/31/2022500 shares $29.00 +400.0%N/A0 $0.06 7/15/2022100 shares $5.99 -99.6%N/A0 $0.06 6/30/202226,200 shares $1.42 thousand +26,100.0%N/A0.1 $0.05 6/15/2022100 shares $5.30 -96.8%N/A0 $0.05 5/31/20223,100 shares $186.00 -54.4%N/A0 $0.06 5/15/20226,800 shares $357.68 +3,300.0%N/A0 $0.05 4/30/2022200 shares $12.28 +100.0%N/A0 $0.06 4/15/2022100 shares $5.86 No ChangeN/A0 $0.06 3/31/2022100 shares $6.74 No ChangeN/A0 $0.07 3/15/2022100 shares $6.92 -96.7%N/A0 $0.07 2/28/20223,000 shares $206.70 +2,900.0%N/A0 $0.07 2/15/2022100 shares $7.00 -98.7%N/A0 $0.07 1/31/20227,700 shares $500.50 -85.4%N/A0 $0.07 1/15/202252,600 shares $3.68 thousand +39.2%N/A0.1 $0.07 12/31/202137,800 shares $2.08 thousand +37,700.0%N/A0 $0.06 12/15/2021100 shares $5.03 -93.8%N/A0 $0.05 11/30/20211,600 shares $85.76 -61.0%N/A0 $0.05 11/15/20214,100 shares $213.61 +4,000.0%N/A0 $0.05 10/29/2021100 shares $5.62 -99.9%N/A0 $0.06 10/15/202190,700 shares $5.59 thousand -24.6%N/A0.4 $0.06 9/30/2021120,300 shares $7.82 thousand +55.8%N/A0.3 $0.07 9/15/202177,200 shares $4.86 thousand -45.4%N/A0.2 $0.06 8/31/2021141,300 shares $8.62 thousand -29.4%N/A0.1 $0.06 8/13/2021200,200 shares $13.91 thousand -22.3%N/A0.5 $0.07 7/30/2021257,500 shares $17.90 thousand +29.7%N/A1 $0.07 7/15/2021198,600 shares $13.90 thousand +13.6%N/A0.4 $0.07 6/30/2021174,900 shares $11.98 thousand -3.6%N/A0.7 $0.07 6/15/2021181,500 shares $12.67 thousand -10.4%N/A0.3 $0.07 5/28/2021202,600 shares $14.91 thousand +9.0%N/A0.5 $0.07 5/14/2021185,800 shares $12.43 thousand +16.1%N/A0.6 $0.07 4/30/2021160,000 shares $10.40 thousand No ChangeN/A0.3 $0.07 4/15/2021160,000 shares $10.75 thousand -14.5%N/A0.5 $0.07 3/31/2021187,200 shares $13.12 thousand +10.1%N/A0.3 $0.07 3/15/2021170,000 shares $11.65 thousand +6.3%N/A0.5 $0.07 2/26/2021160,000 shares $11.68 thousand -34.0%N/A0.3 $0.07 2/12/2021242,400 shares $17.70 thousand +25.9%N/A0.3 $0.07 1/29/2021192,600 shares $14.45 thousand -54.3%N/A0.1 $0.08 1/15/2021299,400 shares $20.90 thousand +76.1%N/A0.4 $0.07 12/31/2020160,500 shares $9.29 thousand -46.4%N/A0.3 $0.06 12/15/2020299,400 shares $17.51 thousand +76.1%N/A0.4 $0.06 11/30/2020170,000 shares $10.88 thousand -1.4%N/A0.3 $0.06 11/15/2020172,400 shares $11.59 thousand -46.8%N/A0.6 $0.07 10/30/2020324,100 shares $22.04 thousand +23.8%N/A0.9 $0.07 10/15/2020261,700 shares $19.89 thousand -44.8%N/A0.5 $0.08 PVCT Short Interest - Frequently Asked Questions What is Provectus Biopharmaceuticals' current short interest? Short interest is the volume of Provectus Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 485,500 shares of PVCT short. Learn More on Provectus Biopharmaceuticals' current short interest. What is a good short interest ratio for Provectus Biopharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PVCT shares currently have a short interest ratio of 1.0. Learn More on Provectus Biopharmaceuticals's short interest ratio. Is Provectus Biopharmaceuticals' short interest increasing or decreasing? Provectus Biopharmaceuticals saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 485,500 shares, an increase of 8.4% from the previous total of 447,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Provectus Biopharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Provectus Biopharmaceuticals: Spero Therapeutics, Inc. (0.81%), Acumen Pharmaceuticals, Inc. (2.90%), Context Therapeutics Inc. (0.86%), TuHURA Biosciences, Inc. (7.73%), Climb Bio, Inc. (1.50%), Zentalis Pharmaceuticals, Inc. (6.29%), Oncolytics Biotech Inc. (2.61%), TScan Therapeutics, Inc. (3.73%), Inhibikase Therapeutics, Inc. (4.27%), Ovid Therapeutics (0.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Provectus Biopharmaceuticals stock? Short selling PVCT is an investing strategy that aims to generate trading profit from Provectus Biopharmaceuticals as its price is falling. PVCT shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Provectus Biopharmaceuticals? A short squeeze for Provectus Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PVCT, which in turn drives the price of the stock up even further. How often is Provectus Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PVCT, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies SPRO Short Interest Data ABOS Short Interest Data CNTX Short Interest Data HURA Short Interest Data CLYM Short Interest Data ZNTL Short Interest Data ONCY Short Interest Data TCRX Short Interest Data IKT Short Interest Data OVID Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PVCT) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
